INDEGENE LIMITED Share Price

INDEGENE LIMITED Share Price

NSE: INDGN
|
Pharmaceuticals
|
S Cap
₹ 580.40
+₹3.05 (0.53%)
1D
Last updated 11 Sep, 2026, 15:29 IST

INDEGENE LIMITED Share Price Today

As of 13 Sep 2026, INDEGENE LIMITED share price is ₹580.40. The stock opened at ₹571.10, compared to its previous close of ₹577.35. During today's trading session, INDEGENE LIMITED share price moved in the range of ₹570.30 to ₹583.25, with an average price of ₹576.77 for the day. Looking at its last 52-week, the stock has touched a low of ₹414.00 and a high of ₹615.50. On the performance front, INDEGENE LIMITED share price has increased by 28.64% over the last six months and is up 1.68% on a year-on-year basis.

₹570.30
0.53% up today
₹583.25
1D LOW
1D HIGH

INDEGENE LIMITED Returns Calculator

Circuit
L
H
₹462.70
₹694.00
52-week
L
H
₹414.00
₹615.50

About INDEGENE LIMITED

INDEGENE LIMITED Share Price
ISIN
INE065X01017
Sector Market Cap
₹ 13,926.65 Cr

Indegene Limited is an India-based tech-native, life sciences commercialization company. The Company provides digital-led commercialization services for the life sciences industry, including biopharmaceutical, emerging biotech, and medical devices companies. Its segments include Enterprise Medical Solutions, Enterprise Commercial Solutions, Brand Activation, and Others. The Enterprise Commercial Solutions business unit caters to the digital marketing operations of life sciences companies. The Enterprise Medical Solutions consolidates large-scale regulatory and medical operations for life sciences companies. The Brand Activation segment offers promotion of biopharmaceutical products and medical devices to HCPs for life sciences companies across channels. It provides customized marketing campaigns through a comprehensive portfolio of proprietary program offerings. Others mainly consist of consultancy and clinical business.

INDEGENE LIMITED Financial Highlights

  • Revenue: INDEGENE LIMITED reported revenue of ₹3,582.50 crore in FY26 vs ₹2,946.50 crore in FY25. It showed an increase of 21.58% on a yearly basis.
  • Operating Profit: INDEGENE LIMITED reported an operating profit of ₹525.00 crore in FY26 vs ₹539.30 crore in FY25. It showed a decrease of 2.65% on a year-on-year basis.
  • Net Profit: INDEGENE LIMITED reported a net profit of ₹401.10 crore in FY26 vs ₹406.70 crore in FY25. It showed a decrease of 1.38% on a yearly basis.

INDEGENE LIMITED Quarterly Result Highlights

  • INDEGENE LIMITED reported revenue of ₹1,092.10 crore in Jun 2026, compared with ₹1,014.20 crore in Mar 2026, representing an increase of 7.68% on a quarter-on-quarter (QoQ) basis.
  • INDEGENE LIMITED reported an operating profit of ₹152.70 crore in Jun 2026, compared with ₹105.10 crore in Mar 2026, representing an increase of 45.29% on a quarter-on-quarter (QoQ) basis.
  • INDEGENE LIMITED reported a profit of ₹116.20 crore in Jun 2026, compared with ₹79.70 crore in Mar 2026, reflecting an increase of 45.80% on a QoQ basis.
  • The earnings per share (EPS) of INDEGENE LIMITED stood at ₹16.72 during Jun 2026.

Data Source: BSE, Company announcements

Securities shown are illustrative, not recommendations. Past performance does not guarantee future results.

Know more
Promoters
0.00%
FII
9.91%
Other DII
3.46%
Retail and other
81.34%
Mutual funds
5.28%
Foreign Institutional Investor (FII)
FII shareholding by period
Sep 202511.30%
Dec 202511.48%
Mar 202610.27%
Jun 20269.91%
Mkt Cap Cr
13,926.70
P/E
34.74
P/B
4.44
ROE
12.78%
D/E
0.03
ROCE
15.61%
Div. Yield
0.39%
EPS(TTM)
8.83
Turnover
0.53
EV/EBITDA
19.66
Net Margin
17.36%
Op. Margin
26.74%
ROA
8.68%
Quick Ratio
4.66
Curr. Ratio
5.06
Based on fundamentals, this stock's
Step 5 of 5
Performance
Excellent
Indegene outperforming all market indices
Step 1 of 5
Valuation
Overvalued
Indegene appears overvalued compared to its peers
Step 4 of 5
Earnings
Good
Indegene revenue, operating profit and net profit are growing
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROED/EROCEBook ValueDiv. YieldTurnoverEPS(TTM)
Apollo Hospitals1,27,249.0058.5913.4220.48%0.3217.27%692.920.23%0.66103.81
Max Healthcare1,00,952.0069.299.4013.42%0.0912.97%91.840.19%0.277.37
MANIPAL HEALTH ENTERPRI L94,200.70103.945.7310.59%0.469.51%0.000.00%0.000.00
Fortis Healthcare66,987.4062.576.7710.53%0.2312.56%122.240.11%0.153.05
Aster DM Healthcare66,504.20183.4015.818.48%0.3110.10%49.230.23%0.435.20
Global Health38,920.5070.479.8214.05%0.0615.26%149.240.03%0.7318.46
Narayana Hrudayalaya38,161.3046.738.4117.76%0.7611.42%127.100.24%0.7624.77
KRISHNA INST OF MED SCI L32,292.20166.068.6210.74%0.637.99%93.540.00%0.426.52
Dr. Lal Path Labs32,049.1058.6612.7820.13%0.0825.56%147.341.07%0.9130.45
Poly Medicure17,610.0056.285.6710.37%0.0812.71%301.170.20%0.4833.15

Auto-generated based on historical fundamentals; not a recommendation to buy/sell.

INDEGENE LIMITED Financials

Full statement

Income Statement · Consolidated

Income Statement · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹3,510.50₹2,839.30₹2,589.60₹2,306.10
Other Income₹72.00₹107.20₹76.30₹58.00
Total Revenue₹3,582.50₹2,946.50₹2,665.90₹2,364.10
Total Expenses₹3,037.20₹2,407.20₹2,209.70₹2,001.10
Profit Before Tax₹525.00₹539.30₹458.60₹363.00
Tax₹123.90₹132.60₹121.90₹96.90
Profit After Tax₹401.10₹406.70₹336.70₹266.10
EPS - Basic₹16.72₹17.15₹15.19₹12.03
EPS - Diluted₹16.62₹17.02₹15.07₹11.97

Cash Flow · Consolidated

Cash Flow · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax₹525.00₹539.30₹458.60₹363.00
Income before WC changes₹652.20₹577.80₹536.80₹454.40
Change in Assets-₹19.60-₹47.70₹1.10-₹174.60
Change in Liabilities₹165.80₹71.80₹94.70-₹41.40
Change in WC₹146.20₹24.10₹95.80-₹216.00
Cash flow from Operations₹650.80₹441.90₹507.70₹130.20
Cash flow from Investing-₹512.40-₹682.70-₹327.20-₹893.30
Cash flow from Financing-₹82.60₹287.50-₹66.20₹333.10
Total Cash Flow₹55.80₹46.70₹114.30-₹430.00
Cash (Start of the year)₹241.00₹188.60₹73.60₹506.30
Cash (End of the year)₹300.80₹241.00₹188.60₹73.60

Balance Sheet · Consolidated

Balance Sheet · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹2,001.90₹795.90₹754.80₹755.20
Current Assets₹2,618.40₹2,530.00₹1,790.80₹1,448.70
Total Assets₹4,620.30₹3,325.90₹2,545.60₹2,203.90
Current Liabilities₹1,086.20₹564.50₹610.90₹489.10
Net Current Asset₹1,532.20₹1,965.50₹1,179.90₹959.60
Non-Current Liabilities₹395.40₹145.80₹505.60₹651.00
Equity Capital₹3,138.70₹2,615.60₹1,429.10₹1,063.80
Total Equity & Liabilities₹4,620.30₹3,325.90₹2,545.60₹2,203.90

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹1,220.60₹1,093.60₹1,045.60₹1,005.70
Other Income₹78.30₹90.40₹50.30₹36.80
Total Revenue₹1,298.90₹1,184.00₹1,095.90₹1,042.50
Total Expenses₹1,017.50₹945.50₹915.30₹865.90
Profit Before Tax₹281.40₹238.50₹180.60₹176.60
Tax₹69.50₹57.20₹42.70₹46.40
Profit After Tax₹211.90₹181.30₹137.90₹130.20
EPS - Basic₹8.83₹7.64₹6.22₹5.89
EPS - Diluted₹8.78₹7.59₹6.17₹5.86

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax₹281.40₹238.50₹180.60₹176.60
Income before WC changes₹265.60₹198.20₹183.10₹209.40
Change in Assets₹122.20₹9.30-₹3.00-₹107.00
Change in Liabilities₹5.70-₹7.90₹45.40₹21.30
Change in WC₹127.90₹1.40₹42.40-₹85.70
Cash flow from Operations₹345.60₹129.00₹176.20₹81.90
Cash flow from Investing-₹272.10-₹824.70-₹187.70-₹47.90
Cash flow from Financing-₹62.60₹717.30-₹15.80-₹16.90
Total Cash Flow₹10.90₹21.60-₹27.30₹17.10
Cash (Start of the year)₹35.20₹13.20₹41.80₹27.80
Cash (End of the year)₹48.50₹35.20₹13.20₹41.80

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹1,207.00₹931.70₹469.30₹334.80
Current Assets₹1,274.90₹1,218.00₹751.00₹702.90
Total Assets₹2,481.90₹2,149.70₹1,220.30₹1,037.70
Current Liabilities₹273.80₹189.50₹198.10₹169.40
Net Current Asset₹1,001.10₹1,028.50₹552.90₹533.50
Non-Current Liabilities₹127.60₹72.00₹68.40₹73.00
Equity Capital₹2,080.50₹1,888.20₹953.80₹795.30
Total Equity & Liabilities₹2,481.90₹2,149.70₹1,220.30₹1,037.70
* All values are in INR Crore
Qty
Bid
700
578.35
0
0
0
0
0
0
0
0
Ask
Qty
0
0
0
0
0
0
0
0
0
0
Bid Total: 700
Ask Total: 0
Buy orders: 100%
Sell orders: 0%
Bearish
1
Neutral
4
Bullish
3
Slightly Bullish
by SEBI experts
Expert Pick
EXPPICK
Stop-loss
Entry price
Target
Indicator
Value
Verdict
RSI (14)
53.07
Neutral
ATR (14)
16.32
Neutral
STOCH(9,6)
18.23
Bullish
STOCH RSI (14)
2.27
Bullish
ADX(9)
29.63
Bearish
UO(9)
45.1
Neutral
ROC(12)
1.52
Bullish
WillR(14)
-64.27
Neutral
Period
Simple value
Exponential vaue
5D
586.12
584.36
10D
594.95
586.16
20D
581.26
579.53
50D
545.88
557.16
100D
531.47
537.29
Volume trend — traded volume by day
11 Sep2L
10 Sep2L
9 Sep2L
8 Sep4L
7 Sep3L
Average2L

Technical indicators used here are for indicative purposes only. Kindly do not treat it as an investment or trading advice

Compare against other stocks
INDEGENE LIMITED Share Price
INDEGENE LIMITED
Pharmaceuticals
Add Stock
Add Another

INDEGENE LIMITED Share Price FAQs

INDEGENE LIMITED share price data is sourced from NSE/BSE and may be delayed. It is displayed for informational purposes only and does not constitute investment advice or a recommendation to buy or sell.

Trusted by 2 Crore+ Indians for their wealth-building needs. SEBI Registered Broker. SEBI Reg No. INZ000315837